Trastuzmap Her2receptoe antagonist breast cancer
Idaurcuzimab antidote of dabigatran
Cetuximab epidermal growth factor receptors
NTAGNOIST metastatic colorectal cancer kras express
Mepolizumab- eosinophilia asthma
Eculizumab- PNH, HUS, meningococcal
Pembrolizumab- mesothelioma
Adalimubab=RA
Omalizumab- asthma with high IgE
Rituximab anticd20 RA NHL
Trastuzmap Her2receptoe antagonist breast cancer
Idaurcuzimab antidote of dabigatran
Cetuximab epidermal growth factor receptors
NTAGNOIST metastatic colorectal cancer kras express
Mepolizumab- eosinophilia asthma
Eculizumab- PNH, HUS, meningococcal
Pembrolizumab- mesothelioma
Adalimubab=RA
Omalizumab- asthma with high IgE
Rituximab anticd20 RA NHL
Vemurafenib and dabrafenib - selective braf inhibitors in metastatic melanoma
Abciximab glycoprotein 2B 3A receptors antagonist prevention of ischemia in patient under go pci